Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Lawrence D. Stern, Chairman and Chief Executive Officer of Talecris, will present at the Goldman Sachs Leveraged Finance Healthcare Conference at 8:15 a.m., Wednesday, Mar. 17 at the Goldman Sachs Conference Center in New York.
A live webcast of Talecris' presentation will be accessible through the investor relations section of the Talecris Web site, www.talecris.com/investor-relations.htm. A replay of the webcast will be available for 30 days following the presentation and can be accessed at the same Web address.
About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.
Contacts:
Talecris Biotherapeutics Holdings Corp.
Investor Relations:
Drayton
Virkler, 919-316-2356
drayton.virkler@talecris.com
or
Corporate
Communications:
Becky Levine, 919-316-6590
becky.levine@talecris.com